Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Alcoholic Fatty Liver Disease (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05742919
What this trial is testing

A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men

Who this might be right for
Non-alcoholic Fatty Liver Disease
Novo Nordisk A/S 24
Testing effectiveness (Phase 2)Ended earlyNCT04147195
What this trial is testing

Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT05795517
What this trial is testing

Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）

Who this might be right for
Hypercholesterolemia
Haisco Pharmaceutical Group Co., Ltd. 210
Not applicableLooking for participantsNCT05720663
What this trial is testing

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Virginia Commonwealth University 240
Testing effectiveness (Phase 2)Ended earlyNCT02787304
What this trial is testing

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis
Mirum Pharmaceuticals, Inc. 197
Testing effectiveness (Phase 2)Study completedNCT00794716
What this trial is testing

PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Norgine 125
Not applicableStudy completedNCT03380416
What this trial is testing

Effects of a Portfolio Diet on NAFLD in Type 2 Diabetic Patients

Who this might be right for
Diabetes Type 2NAFLD
Federico II University 49
Testing effectiveness (Phase 2)Study completedNCT02466516
What this trial is testing

Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Gilead Sciences 72
Testing effectiveness (Phase 2)Study completedNCT05364931
What this trial is testing

Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 54
Early research (Phase 1)Study completedNCT01431521
What this trial is testing

Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)

Who this might be right for
Non-alcoholic Fatty Liver Disease
Merck Sharp & Dohme LLC 31
Early research (Phase 1)Study completedNCT05680233
What this trial is testing

Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver
Oasis Pharmaceuticals, LLC 24
Testing effectiveness (Phase 2)Study completedNCT03912532
What this trial is testing

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 171
Post-approval studies (Phase 4)Ended earlyNCT01406704
What this trial is testing

Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH

Who this might be right for
NASH (Non-alcoholic Steato-hepatitis)
Seoul St. Mary's Hospital 26
Testing effectiveness (Phase 2)Study completedNCT02781584
What this trial is testing

Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Nonalcoholic Fatty Liver Disease (NAFLD)
Gilead Sciences 220
Not applicableStudy completedNCT04988230
What this trial is testing

Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
Nanfang Hospital, Southern Medical University 88
Testing effectiveness (Phase 2)Study completedNCT01963845
What this trial is testing

Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of California, San Diego 50
Not applicableUnknownNCT06365567
What this trial is testing

Dietary Fructose: a Metabolic Switch in Pediatric Obesity-related Disease.

Who this might be right for
Pediatric Obesity
Azienda Ospedaliero Universitaria Maggiore della Carita 100
Not applicableStudy completedNCT07200934
What this trial is testing

Effect of Adding TENS to Mediterranean Diet on Appetite and Liver Enzymes in Nonalcoholic Fatty Liver Patients

Who this might be right for
Nonalcoholic Fatty Liver
Cairo University 50
Early research (Phase 1)Study completedNCT05053165
What this trial is testing

Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants

Who this might be right for
Rheumatoid ArthritisNon-Alcoholic Steatohepatitis
LISCure Biosciences 31
Testing effectiveness (Phase 2)Ended earlyNCT03511365
What this trial is testing

Effects of Probiotic on Inflammation and Microbiota in Patients With NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseProbiotics MeSH Descriptor Data 2018Interleukin-17 MeSH Descriptor Data 2018
Northwell Health 6
Next Page